Literature DB >> 2411342

Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain.

K L Preston, G C Wagner, C R Schuster, L S Seiden.   

Abstract

Previous studies indicate that the repeated administration of D-methylamphetamine (MA) produces a long-lasting depletion of dopamine (DA), norepinephrine (NE) and serotonin (5-hydroxytryptamine, 5-HT) in various brain regions of a number of species. The objectives of the present study were: (1) to establish a short, subcutaneous injection regimen which would reliably produce the neuronal alterations; (2) to evaluate MA-induced NE depletions produced by this new regimen; and (3) to determine whether central MA-induced neuronal changes are reflected in changes in cerebrospinal fluid monoamine metabolite concentrations. It was observed that high doses of MA administered (s.c.) over a 2-week period to rhesus monkeys produced decreases in DA and 5-HT, but not NE levels, in various brain regions. The decrease in caudate DA levels was accompanied by a decrease in the number of DA uptake sites, a decrease in the level of homovanillic acid (HVA) and an increase in DA turnover. This decrease in brain DA was also accompanied by a decrease in the cerebrospinal fluid concentration of HVA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411342     DOI: 10.1016/0006-8993(85)90153-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

Review 1.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 2.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

3.  Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.

Authors:  Bryan A Killinger; Anna Moszczynska
Journal:  J Neurochem       Date:  2015-12-10       Impact factor: 5.372

4.  Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.

Authors:  A Churchyard; C J Mathias; P Boonkongchuen; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

5.  Changes in brain monoamines and their metabolites during and after hemorrhagic shock in the rat.

Authors:  T Mizobe; C Okuda; H Demura; H Tanaka; T Sawa; M Miyazaki; K Kuriyama
Journal:  J Anesth       Date:  1990-04       Impact factor: 2.078

Review 6.  Methamphetamine toxicity and messengers of death.

Authors:  Irina N Krasnova; Jean Lud Cadet
Journal:  Brain Res Rev       Date:  2009-03-25

7.  Brain serotonin transporter in human methamphetamine users.

Authors:  Stephen J Kish; Paul S Fitzmaurice; Isabelle Boileau; Gregory A Schmunk; Lee-Cyn Ang; Yoshiaki Furukawa; Li-Jan Chang; Dennis J Wickham; Allan Sherwin; Junchao Tong
Journal:  Psychopharmacology (Berl)       Date:  2008-10-08       Impact factor: 4.530

8.  Withdrawal from long-term methamphetamine self-administration 'normalizes' neurometabolites in rhesus monkeys: a (1) H MR spectroscopy study.

Authors:  Shaolin Yang; Annabelle M Belcher; Svetlana Chefer; D Bruce Vaupel; Charles W Schindler; Elliot A Stein; Yihong Yang
Journal:  Addict Biol       Date:  2013-08-04       Impact factor: 4.280

9.  Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.

Authors:  Jack D Shepard; David T Chuang; Yavin Shaham; Marisela Morales
Journal:  Psychopharmacology (Berl)       Date:  2006-03-23       Impact factor: 4.530

10.  Acute inhalation exposure to vaporized methamphetamine causes lung injury in mice.

Authors:  Sandra M Wells; Mary C Buford; Sarah N Braseth; James D Hutchison; Andrij Holian
Journal:  Inhal Toxicol       Date:  2008-07       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.